Pasithea Therapeutics (KTTA) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Pasithea Therapeutics Corp   (NASDAQ: KTTA)


Pasithea Therapeutics 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



KTTA Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.00
Gross Profit Margin -
Gross Profit Margin Total Ranking # 592
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Learn about Gross Margin
KTTA's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 86
Healthcare Sector # 153
Overall # 592

Gross Profit Margin Statistics
High Average Low
100.54 % 73.25 % 5.28 %
(Dec 31 2022)   (Mar 31 2022)




Other Gross Profit Margin Profitability Ratios
KTTA's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
KTTA's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for KTTA's Competitors
Gross Profit Margin Profit Margin for Pasithea Therapeutics 's Suppliers
Gross Profit Margin Profit Margin for KTTA's Customers

You may also want to know
KTTA's Annual Growth Rates KTTA's Profitability Ratios KTTA's Asset Turnover Ratio KTTA's Dividend Growth
KTTA's Roe KTTA's Valuation Ratios KTTA's Financial Strength Ratios KTTA's Gross Profit Growth
KTTA's Roa KTTA's Inventory Turnover Ratio KTTA's Growth Rates KTTA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.